SWK Holdings 미래 성장

Future 기준 확인 3/6

SWK Holdings의 수익이 할 전망입니다. 주당 순이익은 성장 연간 35.7%만큼 감소할 것으로 예상됩니다.

주요 정보

34.7%

수익 성장률

35.7%

EPS 성장률

Diversified Financial 수익 성장	-4.1%
매출 성장률	n/a
향후 자기자본 수익률	n/a
애널리스트 커버리지	Low
마지막 업데이트	18 Nov 2024

최근 미래 성장 업데이트

Recent updates

Shareholders May Be More Conservative With SWK Holdings Corporation's (NASDAQ:SWKH) CEO Compensation For Now

Jun 11

Update: SWK Holdings (NASDAQ:SWKH) Stock Gained 46% In The Last Five Years

Feb 16

Here's What SWK Holdings Corporation's (NASDAQ:SWKH) Shareholder Ownership Structure Looks Like

Jan 12

Enteris Biopharma sees growth opportunities in 2021 with potential partnerships in the works

Jan 07

SWK Holdings' subsidiary receives second milestone payment from Cara

Dec 24

A Look At SWK Holdings' (NASDAQ:SWKH) CEO Remuneration

Dec 08

SWK Holdings EPS beats by $0.40, beats on revenue

Nov 13

수익 및 매출 성장 예측

NasdaqGM:SWKH - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
9/30/2024	25	10	22	22	N/A
6/30/2024	26	12	19	19	N/A
3/31/2024	30	12	18	19	N/A
12/31/2023	34	16	14	15	N/A
9/30/2023	34	16	12	12	N/A
6/30/2023	39	18	10	10	N/A
3/31/2023	36	15	4	5	N/A
12/31/2022	38	13	8	8	N/A
9/30/2022	46	17	16	17	N/A
6/30/2022	42	13	18	19	N/A
3/31/2022	58	26	33	34	N/A
12/31/2021	56	26	33	34	N/A
9/30/2021	52	24	31	33	N/A
6/30/2021	53	26	30	33	N/A
3/31/2021	38	13	16	20	N/A
12/31/2020	36	5	15	19	N/A
9/30/2020	33	9	12	14	N/A
6/30/2020	29	9	11	13	N/A
3/31/2020	27	13	15	15	N/A
12/31/2019	28	24	18	19	N/A
9/30/2019	27	20	18	18	N/A
6/30/2019	14	10	21	21	N/A
3/31/2019	15	9	21	21	N/A
12/31/2018	12	6	20	20	N/A
9/30/2018	9	-7	25	25	N/A
6/30/2018	21	2	N/A	22	N/A
3/31/2018	21	1	N/A	22	N/A
12/31/2017	30	3	N/A	19	N/A
9/30/2017	31	35	N/A	12	N/A
6/30/2017	29	35	N/A	10	N/A
3/31/2017	30	31	N/A	10	N/A
12/31/2016	21	29	N/A	10	N/A
9/30/2016	23	2	N/A	11	N/A
6/30/2016	16	-7	N/A	12	N/A
3/31/2016	12	-7	N/A	10	N/A
12/31/2015	12	-7	N/A	11	N/A
9/30/2015	12	14	N/A	10	N/A
6/30/2015	18	20	N/A	7	N/A
3/31/2015	19	22	N/A	7	N/A
12/31/2014	17	21	N/A	5	N/A
9/30/2014	14	15	N/A	3	N/A
6/30/2014	12	15	N/A	3	N/A
3/31/2014	9	14	N/A	2	N/A
12/31/2013	6	13	N/A	1	N/A

애널리스트 미래 성장 예측

수입 대 저축률: SWKH 의 연간 예상 수익 증가율( 34.7% )이 saving rate( 2.6% 보다 높습니다. ).

수익 vs 시장: SWKH 의 연간 수익( 34.7% ) US 시장( 15.4% 보다 빠르게 성장할 것으로 예상됩니다. 15.4% 연간).

고성장 수익: SWKH 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: SWKH 의 수익이 US 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: SWKH 의 수익이 연간 20% 보다 빠르게 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: SWKH 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

SWK Holdings 미래 성장

Future 기준 확인 3/6

주요 정보

최근 미래 성장 업데이트

Price target decreased by 14% to US$22.00

Consensus EPS estimates increase by 20%

Consensus EPS estimates increase by 24%

Consensus revenue estimates increase by 15%

Consensus revenue estimates fall by 17%

Consensus EPS estimates fall by 19%

Recent updates

SWK Holdings: Baby Bond Represents Only Debt And 8.9% Coupon Yield

SWK Holdings Corporation Announces the Promotion of Courtney Baker to Controller

Price target decreased by 14% to US$22.00

SWK Holdings Corporation (NasdaqGM:SWKH) announces an Equity Buyback for $10 million worth of its shares.

New minor risk - Earnings quality

SWK Holdings Corporation, Annual General Meeting, Jun 14, 2024

SWK Holdings Offers Attractive 9% Baby Bond

New major risk - Revenue and earnings growth

New major risk - Revenue and earnings growth

SWK Holdings Corporation to Report Q3, 2023 Results on Nov 09, 2023

SWK Holdings Corporation to Report Q2, 2023 Results on Aug 09, 2023

SWK Holdings Corporation (NasdaqCM:SWKH) announces an Equity Buyback for $10 million worth of its shares.

Consensus EPS estimates increase by 20%

Consensus EPS estimates increase by 24%

High number of new and inexperienced directors

An unknown buyer acquired all shares in Harrow Health, Inc. from SWK Holdings Corporation (NasdaqCM:SWKH).

An unknown buyer acquired all shares in Harrow Health, Inc. from SWK Holdings Corporation (NasdaqCM:SWKH).

SWK Holdings Corporation Names Jody Staggs as Chief Executive Officer

High number of new and inexperienced directors

SWK Holdings Corporation to Report Q3, 2022 Results on Nov 10, 2022

Consensus revenue estimates increase by 15%

SWK Holdings unit receives $5M payment from Cara Therapeutics

SWK Holdings Corporation Promotes John David Tamas to Director of Underwriting

CEO & Chairman exercised options and sold US$475k worth of stock

SWK Holdings Corporation Announces Chief Executive Officer Changes

SWK Holdings announces leadership transition

Consensus revenue estimates fall by 17%

SWK Holdings Corporation to Report Q2, 2022 Results on Aug 11, 2022

SWK Holdings Corporation, Annual General Meeting, Jul 19, 2022

Consensus EPS estimates fall by 19%

High number of new and inexperienced directors

Killer R2K Setup In SWK

High number of new and inexperienced directors

SWK Holdings Corporation Announces Board and Committee Appointments

Carlson Capital, L.P. cancelled the acquisition of remaining 29% stake in SWK Holdings Corporation (NasdaqCM:SWKH).

CEO & Chairman exercised options and sold US$571k worth of stock

Funds managed by Carlson Capital, L.P. has made non-binding proposal to acquire remaining 29% stake in SWK Holdings Corporation.

SWK Holdings Corporation(NasdaqCM:SWKH) dropped from Russell 3000E Value Index

SWK Holdings Corporation (NasdaqCM:SWKH) announces an Equity Buyback for $5 million worth of its shares.

Cannell Capital Provides Information to the Shareholders

Shareholders May Be More Conservative With SWK Holdings Corporation's (NASDAQ:SWKH) CEO Compensation For Now

Consensus forecasts updated

New 90-day high: US$15.09

Update: SWK Holdings (NASDAQ:SWKH) Stock Gained 46% In The Last Five Years

Here's What SWK Holdings Corporation's (NASDAQ:SWKH) Shareholder Ownership Structure Looks Like

Enteris Biopharma sees growth opportunities in 2021 with potential partnerships in the works

SWK Holdings' subsidiary receives second milestone payment from Cara

New 90-day high: US$15.29

Market bids up stock over the past week

A Look At SWK Holdings' (NASDAQ:SWKH) CEO Remuneration

Market pulls back on stock over the past week

SWK Holdings EPS beats by $0.40, beats on revenue

New 90-day high: US$15.15

New 90-day high: US$15.05

New 90-day high - US$14.45

New 90-day high - US$14.22

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견